Aerosol and Liquid Packaging, Inc. – FDA 483, Dec 18, 2023

Aerosol and Liquid Packaging, Inc. in Baltimore, MD, was inspected by the FDA, resulting in 10 observations related to significant deficiencies in their manufacturing processes and quality control. The inspection revealed issues including the use of expired and non-pharmaceutical grade raw materials, lack of proper equipment maintenance and calibration, and a deficient quality control unit. These findings indicate a broad failure to adhere to current good manufacturing practices for drug products.